![]() CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. | |||
Founding Date | Founding Date 2015 | Founding Date 1983 | Founding Date 2009 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Chuo City, JP HQ | Locations Vienna, US HQ | Locations Burnaby, CA HQ Porto, PT Manchester, GB |
Employees | Employees 39 | Employees N/A | Employees N/A |
Valuation ($) | Valuation ($) 64.9 m | Valuation ($) 58.7 m | Valuation ($) 401.7 k |
Financial | |||
Revenue (est.) | Revenue (est.) ¥463m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥4.3m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ¥458.7m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income (¥298.4m) (FY, 2025) | Net income ($25.4m) (FY, 2025) | Net income ($7.1m) (FY, 2022) |

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
View companyAlbert Labs is a clinical research and drug development company.
View company